CHARLES TOWN, W.Va., Oct. 11 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), an emerging medical device manufacturer founded by world-renowned medical device inventor David B. Phillips, Ph.D., today announced it has agreed with Helio Health (http://www.heliohealth.com) to market the ReBuilder System(R) to its customers via the Internet and its mail order catalogs.
"We can bring this new technology from ReBuilder to our customers and because many of our customers are medical professionals looking for new technologies for pain, we feel that this will be a good fit," says Josh Lefkowitz, President of Pain Technologies, parent company to Helio Health. "At Helio Health, we specialize in new products that the physician has not been aware of previously. For example, we released an inexpensive heating/cooling pad for neuropathy patients last year and went from 0 sales to over $800,000 in the first year alone."
"Now even doctors search the Internet for better solutions for their patients," said Brian Sheldon, LPN, Director of Clinical Studies at ReBuilder Medical Technologies, Inc. "Helio Health has an existing following of physicians, nurses and other practitioners that we have not been able to reach to date."
Sheldon said the company will target the addition of 400 new dispensing medical professionals to its customer list in 2007-2008. "Professional unit sales will lead to increased home-use sales, based on product sales history. Home unit sales will generate significant revenues plus dispensable, consumable support items like electrolyte, pads and replacement cables will add to our bottom line."
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc. is a manufacturer of medical devices and innovative technologies founded by world-renowned medical device inventor David B. Phillips, Ph.D. The company's flagship product is its FDA registered ReBuilder System(R), used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery-powered medical product that provides a unique, non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical Technologies, Inc. also manufactures the Phillips Molluscum Treatment System(TM) for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum pathogen without side effects. The company is currently performing research and development on a number of other products as well.
ReBuilder Medical Technologies, Inc. is located in Charles Town, WV. CEO, Dr. David Phillips, Ph.D. is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System, which is used for the early detection of breast cancer, and the AcuPen, a hand-held device that provides the benefits of acupuncture without the use of needles.
More information on ReBuilder Medical Technologies, Inc. and its products can be found at: http://www.rebuildermedical.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
|SOURCE ReBuilder Medical Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved